Enzyme injection tested to stop sepsis damage
NCT ID NCT05453695
Summary
This early-stage study is testing the safety of a new intravenous treatment called DNase I for patients with sepsis in intensive care. The treatment aims to break down harmful webs released by the immune system that can clog blood vessels and damage organs. Researchers will enroll 36 ICU patients to find the safest dose and see if the treatment is practical to administer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEPSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hamilton Health Sciences
RECRUITINGHamilton, Ontario, L8L 0A4, Canada
Contact
Conditions
Explore the condition pages connected to this study.